MarketPeel
DR

Dino A. Rossi

KRYS
DIRECTOR · KRYSTAL BIOTECH, INC. · CIK 0001209059
FILING MIX · LIFETIME33%/67%
BUYS
7
SELLS
14
TOTAL VALUE
$16.68M
COMPANIES
1
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
50,040
AVG SELL PX
$196.68
TRADE KIND
SHOWING 21 / 21
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
3 backtested trades · 8 horizons · 4 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Dino A. Rossi, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d3+33.33%+1.11%+0.82%+0.29%+4.51%
14d3+100.00%-4.41%-0.77%-3.63%-0.43%
30d3+100.00%-3.97%-2.13%-1.84%+1.06%
60d3+0.00%+4.79%+4.25%+0.54%+1.72%
90d3+0.00%+24.11%+7.92%+16.19%+8.16%
180d3+0.00%+34.59%+12.93%+21.67%+13.61%
1y3(2 pending)+0.00%+92.13%+30.67%+61.46%+61.46%
2y3(2 pending)+0.00%+115.96%+54.77%+61.19%+61.19%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
KRYS · 50,040 shares · as of Aug 14, 2026
024,41048,82173,23197,641202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 7 buys / 14 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
KRYS
KRYSTAL BIOTECH, INC.
SALE
7,428$329.60$2.45M58,031Aug 14, 2026Aug 14, 2026View →
KRYS
KRYSTAL BIOTECH, INC.
SALE
40$333.23$13.3K50,000Aug 14, 2026Aug 14, 2026View →
KRYS
KRYSTAL BIOTECH, INC.
SALE
5,226$327.39$1.71M67,146Aug 14, 2026Aug 14, 2026View →
KRYS
KRYSTAL BIOTECH, INC.
SALE
341$325.60$111.0K74,659Aug 14, 2026Aug 14, 2026View →
KRYS
KRYSTAL BIOTECH, INC.
SALE
1,687$328.52$554.2K65,459Aug 14, 2026Aug 14, 2026View →
KRYS
KRYSTAL BIOTECH, INC.
SALEGRANT
Gift
3,69175,000Aug 14, 2026Aug 14, 2026View →
KRYS
KRYSTAL BIOTECH, INC.
SALE
2,287$326.60$746.9K72,372Aug 14, 2026Aug 14, 2026View →
KRYS
KRYSTAL BIOTECH, INC.
SALE
4,896$330.36$1.62M53,135Aug 14, 2026Aug 14, 2026View →
KRYS
KRYSTAL BIOTECH, INC.
SALE
3,095$331.43$1.03M50,040Aug 14, 2026Aug 14, 2026View →
KRYS
KRYSTAL BIOTECH, INC.
SALE
18,9500Feb 19, 2026Feb 23, 2026View →
KRYS
KRYSTAL BIOTECH, INC.
SALE
10,834$262.10$2.84M78,691Feb 19, 2026Feb 23, 2026View →
KRYS
KRYSTAL BIOTECH, INC.
PURCHASE
18,950$8.79$166.6K97,641Feb 19, 2026Feb 23, 2026View →
KRYS
KRYSTAL BIOTECH, INC.
SALE
8,116$260.49$2.11M89,525Feb 19, 2026Feb 23, 2026View →
KRYS
KRYSTAL BIOTECH, INC.
PURCHASEGRANT
Stock grant
5,0005,000Jun 30, 2025Jun 30, 2025View →
KRYS
KRYSTAL BIOTECH, INC.
SALEGRANT
Gift
5,00078,691Sep 13, 2024Sep 13, 2024View →
KRYS
KRYSTAL BIOTECH, INC.
PURCHASEGRANT
Stock grant
5,0005,000Jun 30, 2024Jul 1, 2024View →
KRYS
KRYSTAL BIOTECH, INC.
PURCHASEGRANT
Stock grant
6,8006,800Jun 30, 2023Jul 3, 2023View →
KRYS
KRYSTAL BIOTECH, INC.
SALE
40,000$83.25$3.33M83,691Mar 1, 2023Mar 2, 2023View →
KRYS
KRYSTAL BIOTECH, INC.
PURCHASEGRANT
Stock grant
6,8006,800Jun 30, 2022Jul 1, 2022View →
KRYS
KRYSTAL BIOTECH, INC.
PURCHASEGRANT
Stock grant
6,8006,800Jun 30, 2021Jul 2, 2021View →
KRYS
KRYSTAL BIOTECH, INC.
PURCHASEGRANT
Stock grant
6,8006,800Jun 30, 2020Aug 7, 2020View →
Other insiders · KRYS
Loading peer insiders…
About this filer
CIK 0001209059
ROLE
Director
PRIMARY
KRYS
COMPANIES
1
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001209059DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback